t(8;21) AML-ETO
The AML1-ETO rearrangement t(8;21)(q22;q22) has been reported in acute myeloid leukemia (AML) subtype M2. Synonyms for AML1 (acute myeloid leukemia 1 gene) are PEBP2a (polyoma enhancer binding protein 2 subunit a) or CBFA2 (core binding factor subunit A2) and for ETO (eight twenty one) CDR (cyclin D-related gene) or MTG8 (myeloid translocation gene on chromosome 8).
The breakpoints of AML1 are located between exon 5 and 6 and upstream of exon 2 regarding ETO. The in-frame fusion of AML1 exon 5 to ETO exon 2 can be detected by RT-PCR. Both TaqMan and LightCycler® hybridization probes1,2 based Real-Time PCR methods have been published.
The persistence of t(8;21) makes a quantification detection of fusion gene expression more necessary than a qualitative result with reference to a risk-adapted therapy or a MRD (minimal residual disease) monitoring. The quantification is normalized against a reference gene. In addition of the frequently used glucose-6-phophate dehydrogenase G6PDH 3 (LightMix® Kit 40-0137-16) the Abl1 gene has been recently introduced, following the recommendation of the EU consortium4.
1 Quantitative detection of AML1-ETO rearrangement by real-time RT-PCR using fluorescently labeled probes. Barragan E, Bolufer P, Moreno I, Martin G, Nomdedeu J, Brunet S, Fernandez P, Rivas C, Sanz MA. Leuk Lymph. 42 (2001) 747-756
2 New score predicting for prognosis in PML-RARA+, AML1-ETO+, or CBFBMYH11+ acute myeloid leukemia based on quantification of fusion transcripts . Schnittger et al., Blood (2003)
3 Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR. Emig M. et al., Leukemia (1999) 13, 1825-1832
4 Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) – a Europe against cancer program. Beillard et al. Leukemia. 2003 Dec;17(12):2474-86
Kits
- PRNP
- MTHFR C677T
- N. gonorrhoeae
- C. trachomatis
- PAI 1
- PML-RAR
- G6PDH
- U. urealyticum LC
- CYP2D6*3 *5/*5
- CYP2D6*4 *5/*5
- EBV
- L. pneumophila 16S
- AML-ETO
- HHV-8
- Polyoma JC/BK IC
- L. pneumophila MIP
- VZV
- Inf A H5
- M. pneumoniae P1
- inv 16
- Inf A M2
- NAT2
- HHV-6
- CC_530/640
- JAK2 Mut Screening
- ABL1
- HSV
- bcr-abl
- CMV
- B. pertussis / para
- Inf A swine H1
- InfA M2 and H1 sw TaqMan
- Parvovirus B19
- CYP2D6*3*4
- EHEC
